Ken Ren's Net Worth
$2.47 Million
Who is Ken Ren?
Ken Ren has an estimated net worth of $2.47 Million. This is based on reported shares across multiple companies, which include China Advanced Construction Materials Group, Inc, China Green Agriculture, Inc., and CASI Pharmaceuticals, Inc..
SEC CIK
Ken Ren's CIK is 0001490733
Past Insider Trading and Trends
2016 was Ken Ren's most active year for acquiring shares with 5 total transactions. Ken Ren's most active month to acquire stocks was the month of December. 2016 saw Ken Ren paying a total of $10,894.37 for 215,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
China Advanced Construction Materials Group, Inc No price found
InvestorKen Ren owns 10,000 units of Common Stock, par value $0.001 per share. In the year 2012 Ken Ren filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
China Green Agriculture, Inc. (CGA) Snapshot price: $2.3
Chief Financial OfficerKen Ren owns 1,080,000 units of Common Stock, par value $0.001 which is worth $2,484,000.00. In the year 2010 Ken Ren acquired a total of 1,080,000 shares in China Green Agriculture, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.73% | 200K |
—
|
—
| 1.08M |
Jan 5
| |||
Form 4
| +29.41% | 200K |
—
|
—
| 880K |
Jun 29
| |||
Form 4
| +17.24% | 100K |
—
|
—
| 680K |
Sep 30
| |||
Form 4
| +52.63% | 200K |
—
|
—
| 580K |
Sep 28
| |||
Form 4
| +111.11% | 200K |
—
|
—
| 380K |
Oct 1
| |||
Form 4
| +500.00% | 150K |
—
|
—
| 180K |
Jun 14
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CASI Pharmaceuticals, Inc. No price found
CEO and DirectorKen Ren owns 15,000 units of Common Stock. In the year 2016 Ken Ren filed a total of 1 filing.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15K |
$0.73 | $10,894.37 | 15K |
Jan 19
| |||
| No matching records found | |||||||||